🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalSouth Korea Ozempic availability — 12 month update Page 7

South Korea Ozempic availability — 12 month update

greg_boulder Sat, Aug 16, 2025 at 6:58 AM 40 replies 1,750 viewsPage 7 of 8
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
Sep 5, 2025 at 9:36 PM#31
Dr.AddMedPHL said:
One habit that pays for itself: post the method alongside the number.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

19 19pam_stl, wei_SG, cory_ATX and 16 others
Reply Quote Save Share Report
mike_nyc
VIP Member
5,678
21,345
Nov 2023
New York
Online
Sep 7, 2025 at 1:20 AM#32
Dr.AddMedPHL said:
One habit that pays for itself: post the method alongside the number.

That reframing is the part I needed. Adding it to my notes with a link back to this thread.

18 18stefan_berlin, Dr.EM_Chicago, pete_RVA and 15 others
Reply Quote Save Share Report
LipidDoc_ATL
Senior Member
1,123
5,678
Apr 2024
Atlanta, GA
Sep 8, 2025 at 5:05 AM#33

Adding the clinical framing, because it changes how the question reads. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

Ask again with the specifics and you will get a better answer than this one.

Last edited: Sep 8, 2025 at 10:05 AM
17 17AttorneyGrant, DebRD_ATL, KristenIndy and 14 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
Sep 9, 2025 at 8:50 AM#34
LipidDoc_ATL said:
The version of this that has an answer is narrower than the version being asked.

This matches mine closely enough to be worth saying so out loud. The detail I would add is minor and it is already implied above.

16 16PharmHunterJen, TomTeleRx, DoseLogDan and 13 others
Reply Quote Save Share Report
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Sep 10, 2025 at 12:36 PM#35
LipidDoc_ATL said:
The version of this that has an answer is narrower than the version being asked.

Coming at LipidDoc_ATL’s question from a different direction. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

Last edited: Sep 10, 2025 at 2:36 PM
15 15mike.trainer_LA, sarah_nash92, FitDadDave and 12 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register